Sphere Fluidics

37 articles about Sphere Fluidics

• 

  BioSpace Global Roundup, June 13

  6/13/2019

  Companies from across the globe share business and pipeline updates.

• Sphere Fluidics Closes a $4.8 Million USD (£3.7 Million) Funding Round

  6/10/2019

  Sphere Fluidics announced that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment.

• 

  BioSpace Movers and Shakers: March 29

  3/29/2019

  Biotech and pharma companies bring on new talent to strengthen leadership teams and boards.

• Sphere Fluidics Hires 10 New UK and US Staff in Its Plan to Scale Internationally

  3/26/2019

  Rob Treanor joins as Director of Operations and Andrew Campbell as Director of Finance

• 

  BioSpace's Global Biopharma Roundup: Jan. 31

  1/31/2019

  It’s no secret that the global biopharma and life sciences industry is large. Sometimes the immense size of the industry can lead fascinating news tidbits to fall through the cracks, particularly those from smaller companies scattered across the globe. This week BioSpace will launch a new roundup...

• Sphere Fluidics Closes $2 Million USD (c. £1.5 million GBP) Investment Round

  1/29/2019

  Investment received from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket

• Sphere Fluidics Collaborates with Peak Analysis and Automation to Increase Throughput in Antibody Discovery and Cell Line Development

  1/15/2019

  PAA’s S-LAB micro-plate handling capability will be integrated with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System

• Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite

  9/17/2018

  Sphere Fluidics today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System.

• 

  Biotech Movers and Shakers Aug 20

  8/20/2018

  This past week’s roundup of Movers and Shakers in the biotech industry started with a surprise. Gilead Science’s new(ish) chief medical officer was leaving the company six months after taking over the position.

• Sphere Fluidics Appoints Dr Tris Vaughan as Scientific Advisor

  8/13/2018

  Sphere Fluidics announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB).

• Sphere Fluidics Expands Cyto-Mine Sales Networks and Distribution in US, Europe and Asia

  1/30/2018

  The Company is expanding its direct sales and support activity in North America, having recently opened a sales and support operation in New Jersey, and has established a network of distributors in Europe and the Far East to support the launch of its integrated Cyto-Mine Single Cell Analysis System.

• Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant

  11/27/2017

  €1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project.

• TTP Plc And Sphere Fluidics Introduce Cyto-Mine Single Cell Analysis System

  10/17/2017

  TTP Plc today announced the launch of the award-winning Cyto-Mine Single Cell Analysis System. Recently awarded a Frost and Sullivan award for Product Innovation.

• Sphere Fluidics And Partners Win Major Innovateuk Grant To Develop The World's First Desktop Genome Editing System

  7/17/2017

• Sphere Fluidics Release: Company Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products

  1/24/2017

• Plasticell And Sphere Fluidics Sign Research Collaboration To Develop Gene Transduction Technology Leading To Safer And More Efficient Gene Therapies

  3/29/2016

• Sphere Fluidics Wins $7 Million Investment For Development Of Cyto-Mine - The Unique Single Cell Analysis System

  2/10/2016